Mutual of America Capital Management’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,905
Closed -$69K 1457
2022
Q3
$69K Buy
2,905
+462
+19% +$11K ﹤0.01% 1576
2022
Q2
$55K Buy
2,443
+363
+17% +$8.17K ﹤0.01% 1592
2022
Q1
$52K Buy
2,080
+107
+5% +$2.68K ﹤0.01% 1606
2021
Q4
$71K Buy
1,973
+50
+3% +$1.8K ﹤0.01% 1588
2021
Q3
$82K Sell
1,923
-123
-6% -$5.25K ﹤0.01% 1570
2021
Q2
$89K Buy
2,046
+133
+7% +$5.79K ﹤0.01% 1581
2021
Q1
$78K Buy
1,913
+119
+7% +$4.85K ﹤0.01% 1587
2020
Q4
$81K Buy
1,794
+71
+4% +$3.21K ﹤0.01% 1532
2020
Q3
$61K Buy
1,723
+1,038
+152% +$36.7K ﹤0.01% 1511
2020
Q2
$26K Buy
685
+49
+8% +$1.86K ﹤0.01% 1498
2020
Q1
$18K Buy
636
+123
+24% +$3.48K ﹤0.01% 1507
2019
Q4
$27K Buy
513
+1
+0.2% +$53 ﹤0.01% 1506
2019
Q3
$28K Buy
512
+4
+0.8% +$219 ﹤0.01% 1490
2019
Q2
$21K Buy
508
+100
+25% +$4.13K ﹤0.01% 1551
2019
Q1
$12K Buy
408
+57
+16% +$1.68K ﹤0.01% 1615
2018
Q4
$12K Buy
351
+73
+26% +$2.5K ﹤0.01% 1578
2018
Q3
$12K Sell
278
-70,643
-100% -$3.05M ﹤0.01% 1587
2018
Q2
$2.27M Buy
70,921
+54
+0.1% +$1.73K 0.03% 833
2018
Q1
$3.52M Buy
70,867
+20,400
+40% +$1.01M 0.05% 568
2017
Q4
$2.72M Buy
50,467
+336
+0.7% +$18.1K 0.04% 722
2017
Q3
$2.91M Hold
50,131
0.05% 650
2017
Q2
$2.47M Sell
50,131
-2,750
-5% -$136K 0.04% 727
2017
Q1
$2.3M Sell
52,881
-1,236
-2% -$53.7K 0.04% 738
2016
Q4
$2.65M Sell
54,117
-273
-0.5% -$13.4K 0.05% 635
2016
Q3
$2.6M Hold
54,390
0.05% 601
2016
Q2
$2.92M Sell
54,390
-17,500
-24% -$939K 0.06% 509
2016
Q1
$3.22M Buy
71,890
+500
+0.7% +$22.4K 0.07% 418
2015
Q4
$2.72M Sell
71,390
-733
-1% -$28K 0.06% 502
2015
Q3
$2.3M Hold
72,123
0.05% 572
2015
Q2
$2.38M Hold
72,123
0.05% 621
2015
Q1
$2.97M Sell
72,123
-2,035
-3% -$83.8K 0.06% 498
2014
Q4
$3.02M Buy
74,158
+20,184
+37% +$822K 0.07% 462
2014
Q3
$1.98M Buy
53,974
+14,685
+37% +$538K 0.05% 673
2014
Q2
$1.82M Buy
39,289
+14,654
+59% +$679K 0.04% 740
2014
Q1
$1.01M Buy
+24,635
New +$1.01M 0.02% 972